EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nicotine in Neurodegenerative and Neuropsychiatric Disorders: Mechanisms and Clinical Evidence

Geir Bjørklund iD, Leonard Gurgas, Tony Hangan

Neurochemical Research · 2026-08 · 51 (4)

DOI: 10.1007/s11064-026-04845-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurochemical Research, online erschienen am 03.08.2026. Verfasst von Geir Bjørklund und 2 weiteren Autor:innen. Beteiligte Einrichtung: Council for Nutritional and Environmental Medicine (CONEM), Toften 24, Mo i Rana, 8610, Norway. bjorklund@conem.org. Hauptthemen laut MEDLINE: Nicotine, Neurodegenerative Diseases, Mental Disorders, Nicotinic Agonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 210 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotine, a psychoactive compound primarily known for its role in tobacco addiction, has attracted increasing interest for its neuromodulatory and neuroprotective properties. Acting predominantly through nicotinic acetylcholine receptors, nicotine influences multiple neurotransmitter systems, modulates neuroinflammation, and supports synaptic plasticity. These mechanisms may be therapeutically relevant in disorders characterized by neurodegeneration or disrupted neurocircuitry, including Parkinson’s disease, Alzheimer’s disease, schizophrenia, attention-deficit/hyperactivity disorder, depression, and post-traumatic stress disorder. This review critically examines the current state of preclinical and clinical evidence, with particular attention to receptor subtype activity, cognitive and emotional modulation, and human trial data. Although nicotine’s addictive potential and receptor desensitization remain concerns, advances in selective ligands offer new therapeutic avenues. By consolidating mechanistic insights and disease-specific data, this review highlights both the promise and challenges of developing nicotinic-based therapeutics for brain disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NicotineNeurodegenerative DiseasesMental DisordersNicotinic AgonistsHumansAnimalsReceptors, Nicotinic

Stichwörter der Autor:innen

CognitionNeurodegenerationNicotineNicotinic acetylcholine receptorsParkinson’s diseaseSchizophrenia

Substanzen

NicotineReceptors, NicotinicNicotinic Agonists

Autor:innen und Institutionen

  • Council for Nutritional and Environmental Medicine (CONEM), Toften 24, Mo i Rana, 8610, Norway. bjorklund@conem.org.
  • Faculty of Medicine, Ovidius University of Constanta, Constanta, Romania.

ORCID-Profile: Geir Bjørklund

Zitieren

APA

Bjørklund, G., Gurgas, L., & Hangan, T. (2026). Nicotine in Neurodegenerative and Neuropsychiatric Disorders: Mechanisms and Clinical Evidence. Neurochemical Research, 51(4). https://doi.org/10.1007/s11064-026-04845-0

Vancouver

Bjørklund G, Gurgas L, Hangan T. Nicotine in Neurodegenerative and Neuropsychiatric Disorders: Mechanisms and Clinical Evidence. Neurochemical Research. 2026;51(4). doi:10.1007/s11064-026-04845-0

BibTeX
@article{Bjrklund2026,
  author = {Bjørklund, Geir and Gurgas, Leonard and Hangan, Tony},
  title = {Nicotine in Neurodegenerative and Neuropsychiatric Disorders: Mechanisms and Clinical Evidence},
  journal = {Neurochemical Research},
  year = {2026},
  volume = {51},
  number = {4},
  doi = {10.1007/s11064-026-04845-0}
}
Kostenlos starten →